SCHEMBL5286289

SCHEMBL5286289

Brc1ccccc1CCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.58
HTR1A P08908 1/20 0.48
DRD2 P14416 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
IDO1 P14902 2/20 0.45
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
CASP1 P29466 1/20 0.44
HSD17B10 Q99714 1/20 0.44
FFAR1 O14842 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
GPR52 Q9Y2T5 1/20 0.43
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
CYP2A6 P11509 1/20 0.42
HTR2A P28223 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30364680 1.00 TAAR1 (0.58) TAAR1HTR1ADRD2TDP1IDO1
SCHEMBL29351396 0.87 TAAR1 (0.71) TAAR1IDO1ALDH1A1HSD17B10GPR52
SCHEMBL6738136 0.87 TAAR1 (0.71) TAAR1IDO1ALDH1A1HSD17B10GPR52
SCHEMBL4946934 0.86 TAAR1 (0.54) TAAR1IDO1FFAR1FFAR4GPR52
SCHEMBL29809460 0.86 TAAR1 (0.54) TAAR1TDP1IDO1MAOAMAOB
SCHEMBL55137 0.82 HTR1A (0.58) TAAR1HTR1ADRD2TDP1MAOA
SCHEMBL8406787 0.81 HTR1A (0.46) HTR1ADRD2TDP1ALDH1A1
SCHEMBL8409879 0.80 HTR1A (0.44) TAAR1HTR1ADRD2TDP1IDO1
SCHEMBL423302 0.78 HTR2A (0.56) TAAR1IDO1HPGDHTR2ASMN1; SMN2
Benzene SCHEMBL28195073 0.78 HTR2A (0.56) TAAR1IDO1HPGDHTR2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180090694-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2018-03-29 US disclosed
US-20180090694-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2018-03-29 US disclosed
US-9847499-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-19 US disclosed
US-9847499-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-19 US disclosed
EP-2742054-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-10-12 EP disclosed
CN-103242128-B Preparation method of 9,10-dihydrophenanthrene derivatives UNIV SOOCHOW 2015-02-18 CN disclosed
US-8883816-B2 Fused and spirocycle compounds and the use thereof PURDUE PHARMA L.P. (US) 2014-11-11 US disclosed
US-20140183422-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2014-07-03 US disclosed
US-20140183422-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2014-07-03 US disclosed
US-20140045875-A1 Fused and Spirocycle Compounds and the Use Thereof PURDUE PHARMA L.P. (US) 2014-02-13 US disclosed
EP-0178826-B2 Fungicides SYNGENTA LTD (GB) 2003-04-09 EP disclosed
CN-1377375-A Methanol extraction polar organic compounds and modifier compounds from poly (arylene sulfide) polymer and oligomer streams PHILLIPS PETROLEUM CO (US) 2002-10-30 CN disclosed
CN-1377376-A Recovery of modifier compounds and polar organic compounds from a poly (arylene sulfide) PHILLIPS PETROLEUM CO (US) 2002-10-30 CN disclosed
US-5315025-A Acrylate ethers IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-05-24 US disclosed
US-5286894-A Phenyl acrylic acid derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-02-15 US disclosed
EP-0178826-B1 FUNGICIDES ZENECA LIMITED (GB) 1991-12-18 EP disclosed
EP-0431328-A2 Fungicides ZENECA LIMITED (GB) 1991-06-12 EP disclosed
EP-0178826-A2 Fungicides ZENECA LIMITED (GB) 1986-04-23 EP disclosed
US-4071570-A ANTIARRHYTHMIC AGENTS MERCK & CO., INC. (US) 1978-01-31 US disclosed
US-3978127-A ANTIARRHYTHMIC MERCK & CO., INC. (US) 1976-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180090694-A1 METAL COMPLEXES AP3M1, AP2M1, AP1M1 TAAR1 2452/4885HTR1A 4665/4885DRD2 2191/4885
US-20140045875-A1 Fused and Spirocycle Compounds and the Use Thereof CACNA1A, CACNA1E, CACNA1C TAAR1 1029/4885HTR1A 2015/4885DRD2 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.